Clinical Trial Update: WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial of WAL 801 CL Dry Syrup in pediatric patients with atopic dermatitis. The study, sponsored by Boehringer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• WAL 801 CL Dry Syrup

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED